Arkolith/Insider Trading/ELVN/Form 4

Patel Anish

CHIEF OPERATING OFFICEREnliven Therapeutics, Inc. (ELVN) · full profile →Form 4 · filed Nov 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$116K
Net Open-Market Flow
-$116K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 7, 2025Sell(S)6K$17.35$105K271K
Nov 7, 2025Sell(S)613$17.94$11K270K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001967163-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML